Eiman Ibrahim
Impact in
-
- Cancer Treatment and Pharmacology
- Pancreatic and Hepatic Oncology Research
-
- Parathyroid Disorders and Treatments
Papers in
- Oncology 7
- Cancer Immunotherapy and Biomarkers 4
- Cancer Treatment and Pharmacology 2
-
- Cancer-related cognitive impairment studies 2
- Ferroptosis and cancer prognosis 1
- Co-authors
- Barbara E. Ehrlich (4 shared papers)Naifa L. Busaidy (2 shared papers)Mohamed Elfil (1 shared paper)Kate Nyhan (1 shared paper)Sarah S. Mougalian (1 shared paper)Brenda Cartmel (1 shared paper)Maria E. Cabanillas (1 shared paper)Angelica M. Silva (1 shared paper)
- Journals
- Frontiers in Pediatrics (1 paper)Critical Reviews in Oncology/Hematology (1 paper)Medicine (1 paper)Frontiers in Endocrinology (1 paper)Frontiers in Oncology (1 paper)
- Partner nations
- United StatesSaudi ArabiaPoland
In The Last Decade
Eiman Ibrahim
16 papers receiving 283 citations
Peers
Comparison fields: 5 of 56
- Oncology 145
- Nephrology 36
- Dermatology 20
- Genetics 20
- Pulmonary and Respiratory Medicine 58
Countries citing papers authored by Eiman Ibrahim
This map shows the geographic impact of Eiman Ibrahim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eiman Ibrahim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eiman Ibrahim more than expected).
Fields of papers citing papers by Eiman Ibrahim
This network shows the impact of papers produced by Eiman Ibrahim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eiman Ibrahim. The network helps show where Eiman Ibrahim may publish in the future.
Co-authors
The 25 scholars most cited alongside Eiman Ibrahim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 122 | |
| 2 | 2021 | 39 | |
| 3 | 2019 | 39 | |
| 4 | 2017 | 29 | |
| 5 | 2018 | 11 | |
| 6 | 2022 | 11 | |
| 7 | 2022 | 8 | |
| 8 | 2021 | 6 | |
| 9 | 2024 | 6 | |
| 10 | 2021 | 6 | |
| 11 | 2022 | 3 | |
| 12 | 2022 | 1 | |
| 13 | 2022 | 1 | |
| 14 | 2022 | 1 | |
| 15 | 2020 | 1 | |
| 16 | 2024 | 1 | |
| 17 | 2025 | 0 | |
| 18 | 2025 | 0 | |
| 19 | 2023 | 0 |
About Eiman Ibrahim
Eiman Ibrahim is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Genetics, Endocrinology, Diabetes and Metabolism and Surgery, having authored 19 papers that have together received 285 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (4 papers), Thyroid Cancer Diagnosis and Treatment (3 papers), Glioma Diagnosis and Treatment (3 papers), Cancer-related cognitive impairment studies (2 papers), Cancer Treatment and Pharmacology (2 papers), Radiomics and Machine Learning in Medical Imaging (1 paper), Genetics and Neurodevelopmental Disorders (1 paper) and Ferroptosis and cancer prognosis (1 paper). The work is most often cited by research in Oncology (145 citations), Nephrology (36 citations), Dermatology (20 citations), Genetics (20 citations) and Pulmonary and Respiratory Medicine (58 citations). Eiman Ibrahim has collaborated with scholars based in United States, Saudi Arabia and Poland. Frequent co-authors include Barbara E. Ehrlich, Naifa L. Busaidy, Mohamed Elfil, Kate Nyhan, Sarah S. Mougalian, Brenda Cartmel, Maria E. Cabanillas, Angelica M. Silva, Steven I. Sherman and Mimi I. Hu. Their work appears in journals such as Frontiers in Pediatrics, Critical Reviews in Oncology/Hematology, Medicine, Frontiers in Endocrinology and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.